Skip to main content
DAXOR CORP logo

DAXOR CORP — Investor Relations & Filings

Ticker · DXR ISIN · US2394671034 US Manufacturing
Filings indexed 703 across all filing types
Latest filing 2026-03-24 Director's Dealing
Country US United States of America
Listing US DXR

About DAXOR CORP

https://www.daxor.com/

Daxor Corporation is a medical technology company focused on blood volume measurement. It manufactures and distributes a patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic system. This technology provides clinicians with precise, real-time, quantitative measurements of a patient's total blood volume, red blood cell volume, and plasma volume. The data is utilized to guide optimal fluid management in various clinical settings, such as heart failure, critical care, and hypertension, with the goal of improving patient outcomes. The company is also developing next-generation analyzers and capabilities for remote blood volume monitoring.

Recent filings

Filing Released Lang Actions
4 - DAXOR CORP (0000027367) (Issuer)
Director's Dealing
2026-03-24 English
8-K Filing
Regulatory Filings
2026-01-26 English
424B4 Filing
Prospectus
2026-01-26 English
8-K - DAXOR CORP (0000027367) (Filer)
Regulatory Filings
2026-01-23 English
424B3 Filing
Prospectus
2026-01-23 English
424B3 Filing
Prospectus
2026-01-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.